Key facts
- This page summarizes Deepa Prasad's Form 4 filing for Design Therapeutics, Inc. (DSGN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 Dec 2024, 18:30.
Deepa Prasad - 18 Dec 2024 Form 4 Insider Report for Design Therapeutics, Inc. (DSGN)
- Reporting relationship
- Director
- Issuer ticker
- DSGN
- Reported as of
- 18 Dec 2024
- Net transaction value
- -$23,864
- SEC form
- 4
- Accepted by SEC
- 19 Dec 2024, 18:30:05 UTC
- Prior SEC filing
- 17 Jun 2024
- Next SEC filing
- 12 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mustapha Parekh, Attorney-in-Fact, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Deepa Prasad filed Form 4 for Design Therapeutics, Inc. (DSGN) on 19 Dec 2024.
Change
- Previous filing in this sequence was filed on 17 Jun 2024.
- Current net transaction value: -$23,864.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DSGN
transaction
Common Stock
Sale
- Transaction value
- $23,864
- Shares
- -3,806
- Change %
- -16%
- Price
- $6.27
- Shares after
- 20,000
- Date
- 18 Dec 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.